Literature DB >> 8682880

Early treatment of herpes zoster.

S K Tyring1.   

Abstract

Although varicella virus vaccine may eventually decrease the incidence of herpes zoster, the disease will continue to plague patients and physicians for at least the next several decades. Recognition of shingles early in its vesicular stage is important, since that is when antiviral treatment is effective. Moreover, a variety of agents are now available for symptomatic relief of postherpetic neuralgia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8682880     DOI: 10.1080/21548331.1996.11443319

Source DB:  PubMed          Journal:  Hosp Pract (1995)        ISSN: 2154-8331


  1 in total

1.  A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax.

Authors:  Larry I Gilderman; James F Lawless; Thomas M Nolen; Tina Sterling; Ruth Z Rutledge; Doreen A Fernsler; Neal Azrolan; Santosh C Sutradhar; William W Wang; Ivan S F Chan; Katia Schlienger; Florian Schödel; Jeffrey L Silber
Journal:  Clin Vaccine Immunol       Date:  2007-12-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.